Cargando…

LncRNA MALAT1 gene polymorphisms in coronary artery disease: a case–control study in a Chinese population

Background: Coronary artery disease (CAD) is one of the main fatal diseases all over the world. CAD is a complex disease, which has multiple risk factors mechanisms. In recent years, genome-wide association study (GWAS) had revealed single nucleotide polymorphism genes (SNPs) which were closely rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Weina, Ding, Hanxi, Ouyang, An, Zhang, Xiaohong, Xu, Qian, Han, Yunan, Zhang, Xueying, Jin, Yuanzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422883/
https://www.ncbi.nlm.nih.gov/pubmed/30833365
http://dx.doi.org/10.1042/BSR20182213
_version_ 1783404432199778304
author Hu, Weina
Ding, Hanxi
Ouyang, An
Zhang, Xiaohong
Xu, Qian
Han, Yunan
Zhang, Xueying
Jin, Yuanzhe
author_facet Hu, Weina
Ding, Hanxi
Ouyang, An
Zhang, Xiaohong
Xu, Qian
Han, Yunan
Zhang, Xueying
Jin, Yuanzhe
author_sort Hu, Weina
collection PubMed
description Background: Coronary artery disease (CAD) is one of the main fatal diseases all over the world. CAD is a complex disease, which has multiple risk factors mechanisms. In recent years, genome-wide association study (GWAS) had revealed single nucleotide polymorphism genes (SNPs) which were closely related with CAD risks. The relationship between long non-coding RNA (lncRNA) MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) and CAD risk is largely unknown. To our knowledge, this is the first study which demonstrated the interaction effects of SNP–SNP and SNP–environment with CAD risk. In general, our case–control study is to detect the association between MALAT1 (rs619586, rs4102217) SNPs and CAD risk. Methods: Three hundred and sixty-five CAD patients and three hundred and eighty-four matched control participants blood samples were collected in Liaoning province, China. Two polymorphisms (rs619586, rs4102217) in lncRNA MALAT1 were genotyped by KASP platform. Results: In a stratified analysis, we found that non-drinkers with GC genotype and the recessive model of rs4102217 had higher CAD risk (P=0.010, odds ratio (OR): 1.96, 95% confidence interval (CI) = 1.17–3.28; P=0.026, OR: 1.73, 95% CI = 1.07–2.79) and diabetes mellitus (DM) history group (P=0.010, OR: 4.07, 95% CI = 1.41–11.81; P=0.019, OR: 3.29, 95% CI = 1.22–8.88). In SNP–SNP interactions analysis between MALAT1 and CAD risk, we found rs4102217 had an increase in smokers (GG: OR: 2.04, 95% CI = 1.42–2.92; CC+GC: OR: 2.64, 95% CI = 1.64–4.26) and a decrease in drinkers (CC+GC: OR: 0.33, 95% CI = 0.20–0.55). Smokers with MALAT1 rs619586 AA genotype (OR: 2.20, 95% CI = 1.57–3.07) and GG+AG genotype (OR: 2.11, 95% CI = 1.17–3.81) had a higher risk of CAD. Moreover, drinkers with AA genotype (OR: 0.22, 95% CI = 0.10–0.48) and GG+AG genotype (OR: 0.38, 95% CI = 0.22–0.65) had a lower risk of CAD. According to the MDR software, MALAT1 rs4102217 polymorphism-smoking-drinking was the best interaction model, which has higher risk of CAD (Testing Bal.ACC. = 0.6979). Conclusion: Our study demonstrated that the GC genotype and the recessive model of rs4102217 potentially increased CAD risk in some specific group.
format Online
Article
Text
id pubmed-6422883
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-64228832019-03-27 LncRNA MALAT1 gene polymorphisms in coronary artery disease: a case–control study in a Chinese population Hu, Weina Ding, Hanxi Ouyang, An Zhang, Xiaohong Xu, Qian Han, Yunan Zhang, Xueying Jin, Yuanzhe Biosci Rep Research Articles Background: Coronary artery disease (CAD) is one of the main fatal diseases all over the world. CAD is a complex disease, which has multiple risk factors mechanisms. In recent years, genome-wide association study (GWAS) had revealed single nucleotide polymorphism genes (SNPs) which were closely related with CAD risks. The relationship between long non-coding RNA (lncRNA) MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) and CAD risk is largely unknown. To our knowledge, this is the first study which demonstrated the interaction effects of SNP–SNP and SNP–environment with CAD risk. In general, our case–control study is to detect the association between MALAT1 (rs619586, rs4102217) SNPs and CAD risk. Methods: Three hundred and sixty-five CAD patients and three hundred and eighty-four matched control participants blood samples were collected in Liaoning province, China. Two polymorphisms (rs619586, rs4102217) in lncRNA MALAT1 were genotyped by KASP platform. Results: In a stratified analysis, we found that non-drinkers with GC genotype and the recessive model of rs4102217 had higher CAD risk (P=0.010, odds ratio (OR): 1.96, 95% confidence interval (CI) = 1.17–3.28; P=0.026, OR: 1.73, 95% CI = 1.07–2.79) and diabetes mellitus (DM) history group (P=0.010, OR: 4.07, 95% CI = 1.41–11.81; P=0.019, OR: 3.29, 95% CI = 1.22–8.88). In SNP–SNP interactions analysis between MALAT1 and CAD risk, we found rs4102217 had an increase in smokers (GG: OR: 2.04, 95% CI = 1.42–2.92; CC+GC: OR: 2.64, 95% CI = 1.64–4.26) and a decrease in drinkers (CC+GC: OR: 0.33, 95% CI = 0.20–0.55). Smokers with MALAT1 rs619586 AA genotype (OR: 2.20, 95% CI = 1.57–3.07) and GG+AG genotype (OR: 2.11, 95% CI = 1.17–3.81) had a higher risk of CAD. Moreover, drinkers with AA genotype (OR: 0.22, 95% CI = 0.10–0.48) and GG+AG genotype (OR: 0.38, 95% CI = 0.22–0.65) had a lower risk of CAD. According to the MDR software, MALAT1 rs4102217 polymorphism-smoking-drinking was the best interaction model, which has higher risk of CAD (Testing Bal.ACC. = 0.6979). Conclusion: Our study demonstrated that the GC genotype and the recessive model of rs4102217 potentially increased CAD risk in some specific group. Portland Press Ltd. 2019-03-19 /pmc/articles/PMC6422883/ /pubmed/30833365 http://dx.doi.org/10.1042/BSR20182213 Text en © 2019 The Author(s). http://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Articles
Hu, Weina
Ding, Hanxi
Ouyang, An
Zhang, Xiaohong
Xu, Qian
Han, Yunan
Zhang, Xueying
Jin, Yuanzhe
LncRNA MALAT1 gene polymorphisms in coronary artery disease: a case–control study in a Chinese population
title LncRNA MALAT1 gene polymorphisms in coronary artery disease: a case–control study in a Chinese population
title_full LncRNA MALAT1 gene polymorphisms in coronary artery disease: a case–control study in a Chinese population
title_fullStr LncRNA MALAT1 gene polymorphisms in coronary artery disease: a case–control study in a Chinese population
title_full_unstemmed LncRNA MALAT1 gene polymorphisms in coronary artery disease: a case–control study in a Chinese population
title_short LncRNA MALAT1 gene polymorphisms in coronary artery disease: a case–control study in a Chinese population
title_sort lncrna malat1 gene polymorphisms in coronary artery disease: a case–control study in a chinese population
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422883/
https://www.ncbi.nlm.nih.gov/pubmed/30833365
http://dx.doi.org/10.1042/BSR20182213
work_keys_str_mv AT huweina lncrnamalat1genepolymorphismsincoronaryarterydiseaseacasecontrolstudyinachinesepopulation
AT dinghanxi lncrnamalat1genepolymorphismsincoronaryarterydiseaseacasecontrolstudyinachinesepopulation
AT ouyangan lncrnamalat1genepolymorphismsincoronaryarterydiseaseacasecontrolstudyinachinesepopulation
AT zhangxiaohong lncrnamalat1genepolymorphismsincoronaryarterydiseaseacasecontrolstudyinachinesepopulation
AT xuqian lncrnamalat1genepolymorphismsincoronaryarterydiseaseacasecontrolstudyinachinesepopulation
AT hanyunan lncrnamalat1genepolymorphismsincoronaryarterydiseaseacasecontrolstudyinachinesepopulation
AT zhangxueying lncrnamalat1genepolymorphismsincoronaryarterydiseaseacasecontrolstudyinachinesepopulation
AT jinyuanzhe lncrnamalat1genepolymorphismsincoronaryarterydiseaseacasecontrolstudyinachinesepopulation